The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
UDP-glucuronosyltransferases and clinical drug-drug interactions
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
Tukey, R. H., & Strassburg, C. P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.581 · Cited by 1,523
Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., Gigleux, S. F., Green, M., Hum, D. W., Iyanagi, T., et al. (1997) · Pharmacogenetics · doi:10.1097/00008571-199708000-00001 · Cited by 1,183
Williams, J. A., Hyland, R., Jones, B. C., Smith, D. A., Hurst, S., Goosen, T. C., Peterkin, V., Koup, J. R., & Ball, S. E. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000794 · Cited by 928
Dresser, G. K., Spence, J. D., & Bailey, D. G. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038010-00003 · Cited by 908
Ando, Y., Saka, H., Ando, M., Sawa, T., Muro, K., Ueoka, H., Yokoyama, A., Saitoh, S., Shimokata, K., & Hasegawa, Y. (2000) · PubMed · Cited by 783
UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity
Iyer, L., Das, S., Janisch, L., Wen, M., Ramírez, J., Karrison, T., Fleming, G. F., Vokes, E. E., Schilsky, R. L., & Ratain, M. J. (2002) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500072 · Cited by 720
Update: Clinically Significant Cytochrome P‐450 Drug Interactions
Michalets, E. L. (1998) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03830.x · Cited by 597
Human UGT2B7 catalyzes morphine glucuronidation.
Coffman, B. L., Rios, G. R., King, C. D., & Tephly, T. R. (1997) · PubMed · Cited by 481
How Important Are Gender Differences in Pharmacokinetics?
Meibohm, B., Beierle, I., & Derendorf, H. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241050-00002 · Cited by 454
Pichard, L., Fabre, I., Fabre, G., Domergue, J., Saint Aubert, B., Mourad, G., & Maurel, P. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08600-3 · Cited by 433
Pharmacogenomics of human UDP-glucuronosyltransferase enzymes
Guillemette, C. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500171 · Cited by 425
Glucuronidation in Humans: Pharmacogenetic and Developmental Aspects
de Wildt, S. N., Kearns, G. L., Leeder, J. S., & van den Anker, J. N. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00005 · Cited by 393
Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions
Ritter, J. K. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00198-8 · Cited by 386
The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*†
Fisher, M. B., Paine, M. F., Strelevitz, T. J., & Wrighton, S. A. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-120000653 · Cited by 375
Xie, W., Yeuh, M.-F., Radominska-Pandya, A., Saini, S. P. S., Negishi, Y., Bottroff, B. S., Cabrera, G. Y., Tukey, R. H., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438010100 · Cited by 367
McCarver, D. G., & Hines, R. N. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.361 · Cited by 366
Uchaipichat, V., Mackenzie, P. I., Guo, X.-H., Gardner-Stephen, D., Galetin, A., Houston, J. B., & Miners, J. O. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.4.413 · Cited by 335
Turgeon, D., Carrier, J.-S., Lévesque, E., Hum, D. W., & Bélanger, A. (2001) · Endocrinology · doi:10.1210/endo.142.2.7958 · Cited by 333
Rae, J. M., Johnson, M. D., Lippman, M. E., & Flockhart, D. A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29202-8 · Cited by 306
Court, M. H., Duan, S. X., von Moltke, L. L., Greenblatt, D. J., Patten, C. J., Miners, J. O., & Mackenzie, P. I. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29222-3 · Cited by 301
Inherited disorders of bilirubin metabolism
Bosma, P. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00359-8 · Cited by 279
Expression of the UDP-glucuronosyltransferase 1A Locus in Human Colon
Strassburg, C. P., Manns, M. P., & Tukey, R. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8719 · Cited by 277
Strassburg, C. P., Oldhafer, K., Manns, M. P., & Tukey, R. H. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.2.212 · Cited by 275
Green, M. D., King, C. D., Mojarrabi, B., Mackenzie, P. I., & Tephly, T. R. (1998) · PubMed · Cited by 253
Sodium valproate acutely inhibits lamotrigine metabolism.
Yuen, A., Land, G., Weatherley, B., & Peck, A. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04079.x · Cited by 252
Court, M. H., Krishnaswamy, S., Hao, Q., Duan, S. X., Patten, C. J., von Moltke, L. L., & Greenblatt, D. J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.9.1125 · Cited by 251
Bhasker, C. R., McKinnon, W., Stone, A., Lo, A. C., Kubota, T., Ishizaki, T., & Miners, J. O. (2000) · Pharmacogenetics · doi:10.1097/00008571-200011000-00002 · Cited by 245
Rifampin and Rifabutin Drug Interactions: An Update
Finch, C. K., Chrisman, C. R., Baciewicz, A. M., & Self, T. H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.9.985 · Cited by 233
Bernard, O., & Guillemette, C. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.8.775 · Cited by 228
Zucker, K., Rosen, A., Tsaroucha, A., de Faria, L., Roth, D., Ciancio, G., Esquenazi, V., Burke, G., Tzakis, A., & Miller, J. (1997) · Transplant Immunology · doi:10.1016/s0966-3274(97)80042-1 · Cited by 227
Jin, C., Miners, J. O., Lillywhite, K. J., & Mackenzie, P. I. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10294-2 · Cited by 226
Levesque, E., Beaulieu, M., GreeN, M. D., Tephly, T. R., Belanger, A., & Hum, D. W. (1997) · Pharmacogenetics · doi:10.1097/00008571-199708000-00007 · Cited by 218
Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance
Miners, J. O., McKinnon, R. A., & Mackenzie, P. I. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00449-3 · Cited by 210
Miners, J. O., Smith, P. A., Sorich, M. J., McKinnon, R. A., & Mackenzie, P. I. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121546 · Cited by 210
Stone, A. N., Mackenzie, P. I., Galetin, A., Houston, J. B., & Miners, J. O. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.9.1086 · Cited by 206
Lampe, J. W., Bigler, J., Horner, N. K., & Potter, J. D. (1999) · Pharmacogenetics · doi:10.1097/00008571-199906000-00009 · Cited by 205
Chang, T. K. H., Yu, L., Maurel, P., & Waxman, D. J. (1997) · PubMed · Cited by 195
Self-citationLamotrigine: An Update of its Pharmacology and Therapeutic Use in Epilepsy
Fitton, A., & Goa, K. L. (1995) · Drugs · doi:10.2165/00003495-199550040-00008 · Cited by 194
Kemp, D. C., Fan, P. W., & Stevens, J. C. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.6.694 · Cited by 193
Tanaka, E. (1998) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.1998.00086.x · Cited by 192
Beaulieu, M., Lávesque, E., Hum, D. W., & Bálanger, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22855 · Cited by 187
Influence of sex and oral contraceptive steroids on paracetamol metabolism.
Miners, J., Attwood, J., & Birkett, D. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02207.x · Cited by 184
Court, M. H., Duan, S. X., Guillemette, C., Journault, K., Krishnaswamy, S., von Moltke, L. L., & Greenblatt, D. J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.11.1257 · Cited by 174
King, C. D., Green, M. D., Rios, G. R., Coffman, B. L., Owens, I. S., Bishop, W. P., & Tephly, T. R. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0320 · Cited by 169
King, C. D., Rios, G. R., Assouline, J. A., & Tephly, T. R. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1155 · Cited by 165
Armstrong, S. C., & Cozza, K. L. (2003) · Psychosomatics · doi:10.1176/appi.psy.44.2.167 · Cited by 164
Holthe, M., Rakvåg, T. N., Klepstad, P., Idle, J. R., Kaasa, S., Krokan, H. E., & Skorpen, F. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500139 · Cited by 163
Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome
De Morais, S. M. F., Uetrecht, J. P., & Wells, P. G. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90106-9 · Cited by 160
King, C. (2001) · Toxicological Sciences · doi:10.1093/toxsci/61.1.49 · Cited by 159
Hanioka, N., Ozawa, S., Jinno, H., Ando, M., Saito, Y., & Sawada, J. (2001) · Xenobiotica · doi:10.1080/00498250110057341 · Cited by 158
Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.
Cheng, Z., Radominska-p, A., & Tephly, T. R. (1999) · PubMed · Cited by 154
AN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTES
Soars, M. G., Petullo, D. M., Eckstein, J. A., Kasper, S. C., & Wrighton, S. A. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.1.140 · Cited by 152
THE EFFECT OF INCUBATION CONDITIONS ON THE ENZYME KINETICS OF UDP-GLUCURONOSYLTRANSFERASES
Soars, M. G., Ring, B. J., & Wrighton, S. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.6.762 · Cited by 152
Ciotti, M., Basu, N. K., Brangi, M., & Owens, I. S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0453 · Cited by 141
Lévesque, É., Turgeon, D. K., Carrier, J.-S., Montminy, V., Beaulieu, M., & Bélanger, A. (2001) · Biochemistry · doi:10.1021/bi002607y · Cited by 137
New Antiepileptic Drugs: Review on Drug Interactions
Hachad, H., Ragueneau, I., & Levy, R. H. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200202000-00016 · Cited by 134
van Holthe, M. S. T., Klepstad, P., Zahlsen, K., Borchgrevink, P. C., Hagen, L., Dale, O., Kaasa, S., Krokan, H. E., & Skorpen, F. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0490-1 · Cited by 133
Houston, J. B. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90056-5 · Cited by 133
Regulation of UDP Glucuronosyltransferase Genes
Mackenzie, P. I., Gregory, P. A., Gardner-Stephen, D. A., et al. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489442 · Cited by 129
Expressed human UGT1.4 protein catalyzes the formation of quaternary ammonium-linked glucuronides.
Green, M. D., Bishop, W. P., & Tephly, T. R. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06536-5 · Cited by 124
McGurk, K. A., Brierley, C. H., & Burchell, B. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00534-0 · Cited by 123
Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase
Jedlitschky, G., Cassidy, A., Sales, M., Pratt, N. R., & Burchell, B. (1999) · Biochemical Journal · doi:10.1042/bj3400837 · Cited by 120
Münzel, P., Schmohl, S., Heel, H., Kälberer, K., Bock-Hennig, B. S., & Bock, K. W. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15251-8 · Cited by 119
Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms
Sakaguchi, K., Green, M. D., Stock, N. S., Reger, T. S., Zunic, J., & King, C. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.02.004 · Cited by 115
Veal, G. J., & Back, D. J. (1995) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)00047-x · Cited by 114
Trapnell, C. B., Klecker, R. W., Jamis‐Dow, C., & Collins, J. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1592 · Cited by 113
Cloning and Expression of Human UDP-Glucuronosyltransferase (UGT) 1A8
Cheng, Z., Radominska-p, A., & Tephly, T. R. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0781 · Cited by 113
The Clinical Management and Outcome of Nail Salon–Acquired Mycobacterium fortuitum Skin Infection
Winthrop, K. L., Albridge, K., South, D. A., Albrecht, P., Abrams, M., Samuel, M. C., Leonard, W., Wagner, J., & Vugia, D. J. (2003) · Clinical Infectious Diseases · doi:10.1086/380459 · Cited by 109
Nishiyama, T., Ogura, K., Nakano, H., Ohnuma, T., Kaku, T., Hiratsuka, A., Muro, K., & Watabe, T. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00994-2 · Cited by 109
Sugatani, J., Yamakawa, K., Tonda, E., Nishitani, S., Yoshinari, K., Degawa, M., Abe, I., Noguchi, H., & Miwa, M. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.11.002 · Cited by 107
Serum Concentrations of Lamotrigine in Epileptic Patients: The Influence of Dose and Comedication
May, T. W., Rambeck, B., & Jürgens, U. H. (1996) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199610000-00001 · Cited by 105
Loss of analgesic effect of morphine due to coadministration of rifampin
Fromm, M. F., Eckhardt, K., Li, S., et al. (1997) · Pain · doi:10.1016/s0304-3959(97)00044-4 · Cited by 104
Köhle, C., Möhrle, B. P., Münzel, P., Schwab, M. G., Wernet, D., Badary, O. A., & Bock, K. W. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00074-1 · Cited by 102
May, T. W., Rambeck, B., & Jürgens, U. H. (1999) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199904000-00007 · Cited by 101
Genetic Variation of Human UDP-Glucuronosyltransferase
Burchell, B. (2003) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200303010-00006 · Cited by 100
Gallicano, K., Sahai, J. V., Shukla, V. K., et al. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00987.x · Cited by 100
PROBENECID AND ZIDOVUDINE METABOLISM
Kornhauser, D. M., Hendrix, C. W., Nerhood, L., Petty, B., Woods, A. S., Bartlett, J., & Ps, L. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92087-4 · Cited by 99
Sahai, J. V., Gallicano, K., Pakuts, A. P., & Cameron, D. W. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.5.1103 · Cited by 98
Fujino, H., Yamada, I., Shimada, S., Yoneda, M., & Kojima, J. (2003) · Xenobiotica · doi:10.1080/0049825021000017957 · Cited by 96
Adding valproate to lamotrigine: A study of their pharmacokinetic interaction
Kanner, A. M., & Frey, M. (2000) · Neurology · doi:10.1212/wnl.55.4.588 · Cited by 96
Glucuronidation Activity of the UGT2B17 Enzyme toward Xenobiotics
Turgeon, D. K., Carrier, J.-S., Chouinard, S., & Bélanger, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.5.670 · Cited by 96
Bock, K. W., Wiltfang, J., Blume, R., Ullrich, D., & Bircher, J. (1987) · European Journal of Clinical Pharmacology · doi:10.1007/bf00541295 · Cited by 95
Walle, T., Otake, Y., Galijatovic, A., Ritter, J. K., & Walle, U. K. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15189-6 · Cited by 92
N-Glucuronidation of Carbamazepine in Human Tissues Is Mediated by UGT2B7
Staines, A. G., Coughtrie, M. W. H., & Burchell, B. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073114 · Cited by 92
Lautala, P., Ethell, B. T., Taskinen, J., & Burchell, B. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15088-x · Cited by 90
Effects of microsomal enzyme induction on paracetamol metabolism in man.
Prescott, L., Critchley, J., Balali‐Mood, M., & Pentland, B. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01193.x · Cited by 88
Bartoli, A., Guerrini, R., Belmonte, A., et al. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199706000-00002 · Cited by 84
Ebert, U., Thong, N. Q., Oertel, R., et al. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280000146 · Cited by 83
Abernethy, D. R., Greenblatt, D. J., Ameer, B., & Shader, R. I. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23469-3 · Cited by 82
Isolation and Characterization of a Human Orphan UDP-Glucuronosyltransferase, UGT2B11
Beaulieu, M., Lévesque, É., Hum, D. W., & Bélanger, A. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8908 · Cited by 81
Pharmacokinetic interaction between rifampin and zidovudine
Burger, D. M., Meenhorst, P. L., Koks, C. H. W., & Beijnen, J. H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1426 · Cited by 81
Watanabe, Y., Nakajima, M., & Yokoi, T. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.12.1462 · Cited by 81
Münzel, P., Schmohl, S., Buckler, F., Jaehrling, J., Raschko, F. T., Köhle, C., & Bock, K. W. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00389-7 · Cited by 80
Polymorphisms of UDP-Glucuronosyltransferase and Pharmacokinetics of Irinotecan
Ando, Y., Ueoka, H., Sugiyama, T., Ichiki, M., Shimokata, K., & Hasegawa, Y. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200202000-00018 · Cited by 77
Barrand, M. A., Bagrij, T., & Neo, S.-Y. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00284-4 · Cited by 76
Kaku, T., Ogura, K., Nishiyama, T., Ohnuma, T., Muro, K., & Hiratsuka, A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.02.014 · Cited by 71
Posner, J., Cohen, A., Land, G., Winton, C., & Peck, A. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03514.x · Cited by 69
Bernard, P., Goudonnet, H., Artur, Y., Desvergne, B., & Wahli, W. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.3.526 · Cited by 67
Dilger, K. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.106872 · Cited by 66
The Human UDP Glucuronosyltransferase, UGT1A10, Glucuronidates Mycophenolic Acid
Mojarrabi, B., & Mackenzie, P. I. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7388 · Cited by 65
Effects of oral contraceptive steroids on acetaminophen metabolism and elimination
Mitchell, M. C., Hanew, T., Meredith, C. G., & Schenker, S. (1983) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1983.127 · Cited by 64
Sim, S. M., Back, D., & Breckenridge, A. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb05607.x · Cited by 63
INVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOL
Ohno, A., Saito, Y., Hanioka, N., Jinno, H., Saeki, M., Ando, M., Ozawa, S., & Sawada, J. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.2.235 · Cited by 62
Effect of Valproate on the Pharmacokinetics and Pharmacodynamics of Lorazepam
Samara, E. E., Granneman, R. G., Witt, G. F., et al. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04322.x · Cited by 55
Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome
Ullrich, D., Sieg, A., Blume, R., et al. (1987) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1987.tb01242.x · Cited by 54
Caraco, Y., Sheller, J. R., & Wood, A. J. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36560-7 · Cited by 54
Glucuronidation of 3′-azido-3′-deoxythymidine catalyzed by human liver UDP-glucuronosyltransferase
Resetar, A. M., Minick, D. J., & Spector, T. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90319-z · Cited by 49
Nonsteroidal anti-inflammatory drugs and phenols glucuronidation in Caco-2 cells
Sabolovic, N., Magdalou, J., Netter, P., & Abid, A. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00616-0 · Cited by 46
The effect of probenecid on paracetamol metabolism and pharmacokinetics
Kamali, F. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315313 · Cited by 43
Lorazepam‐Valproate Interaction: Studies in Normal Subjects and Isolated Perfused Rat Liver
Anderson, G. D., Gidal, B. E., Kantor, E. D., et al. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02937.x · Cited by 42
Heterogeneity of paracetamol metabolism in Gilbert’s syndrome
Esteban, Á., & Pérez‐Mateo, M. (1999) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190005 · Cited by 41
Collier, A. C., Keelan, J. A., van Zijl, P. E., Paxton, J. W., Mitchell, M. D., & Tingle, M. D. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.8.813 · Cited by 38
The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers
Markowitz, J. S., DeVane, C. L., Liston, H. L., Boulton, D. W., & Risch, S. C. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.119815 · Cited by 37
Gregory, P. A., & Mackenzie, P. I. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.154 · Cited by 32
Antiepileptic-Antipsychotic Drug Interactions: A Critical Review of the Evidence
Mula, M., & Monaco, F. (2002) · Clinical Neuropharmacology · doi:10.1097/00002826-200209000-00012 · Cited by 29
Metz, R. P., Auyeung, D. J., Kessler, F. K., & Ritter, J. K. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.319 · Cited by 29
Severe Anemia Secondary to a Probable Drug Interaction between Zidovudine and Valproic Acid
Antoniou, T., Gough, K. A., Yoong, D., & Arbess, G. (2004) · Clinical Infectious Diseases · doi:10.1086/381760 · Cited by 24
In vitro characterization of the biotransformation of thiocoraline, a novel marine anti-cancer drug
Brandon, E. F. A., Sparidans, R. W., Meijerman, I., Manzanares, I., Beijnen, J. H., & Schellens, J. H. M. (2004) · Investigational New Drugs · doi:10.1023/b:drug.0000026250.34645.7f · Cited by 22
The effect of propranolol on paracetamol metabolism in man.
Baraka, O., Truman, C. A., Ford, J., & Roberts, C. J. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03631.x · Cited by 21
Wahlström, A., Persson, K., & Rane, A. (1989) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08747-1 · Cited by 20
Furuta, S., Akagawa, N., Kamada, E., Hiyama, A., Kawabata, Y., Kowata, N., Inaba, A., Matthews, A., Hall, M., & Kurimoto, T. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01649.x · Cited by 20
Gaiser, B. K., Lockley, D. J., Staines, A. G., Bäärnhielm, C., & Burchell, B. (2003) · Xenobiotica · doi:10.1080/00498250310001609129 · Cited by 19
Macleod, R., Eagling, V. A., Sim, S. M., & Back, D. J. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90303-z · Cited by 16
The effects of indomethacin and naproxen on zidovudine pharmacokinetics.
Barry, M. G., Howe, J., Back, D. J., Breckenridge, A., Brettle, R. P., Mitchell, R., Beeching, N. J., & Nye, F. J. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb05898.x · Cited by 16
Zhou, S., Kestell, P., & Paxton, J. W. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120015693 · Cited by 15
Cisapride raises the bioavailability of paracetamol by inhibiting its glucuronidation in man
Itoh, H., Nagano, T., & Takeyama, M. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011776298 · Cited by 10
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification
Rowland, A., Miners, J. O., & Mackenzie, P. I. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.019 · Cited by 709
PHASE II DRUG METABOLIZING ENZYMES
Jancova, P., Anzenbacher, P., & Anzenbacherova, E. (2010) · Biomedical Papers · doi:10.5507/bp.2010.017 · Cited by 603
Enzyme induction with antiepileptic drugs: Cause for concern?
Brodie, M. J., Mintzer, S., Pack, A. M., Gidal, B. E., Vecht, C. J., & Schmidt, D. (2013) · Epilepsia · doi:10.1111/j.1528-1167.2012.03671.x · Cited by 383
Impact of Obesity on Drug Metabolism and Elimination in Adults and Children
Brill, M. J. E., Diepstraten, J., van Rongen, A., van Kralingen, S., van den Anker, J. N., & Knibbe, C. A. J. (2012) · Clinical Pharmacokinetics · doi:10.2165/11599410-000000000-00000 · Cited by 382
Metadata
- Authors
- KIANG, T., ENSOM, M., & CHANG, T.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 106
- Issue
- 1
- Pages
- 97-132
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1985410301
- Cited by
- 552
- References
- 127
- FWCI
- 19.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.